Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02395445Not ApplicableCompleted

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Routine Airway Management

Role: lead

NCT02395406Not ApplicableUnknown

A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Difficult Airway Management

Role: lead

NCT02395419Not ApplicableUnknown

A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Routine Airway Management

Role: lead

NCT02395432Not ApplicableCompleted

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Difficult Airway

Role: lead

NCT01458431Phase 3Completed

Levobupivacaine to the Surgical Wound Following Cesarean

Role: lead

NCT01311284Not ApplicableCompleted

Comparison Airway Devices in Nasotracheal Intubation in Manikin

Role: lead

All 6 trials loaded